PharmaCyte Biotech (PMCB) EBITDA Margin Growth (1y) (2011 - 2012)
PharmaCyte Biotech (PMCB) EBITDA Margin Growth (1y) (2011 - 2012) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.93 Bn | 131.07 Bn | 2.84 Bn | -143.00 |
| 2 | Regeneron Pharmaceuticals | 85.91 Bn | 77.92 Bn | 3.93 Bn | 78.00 |
| 3 | Argenx Se | 64.98 Bn | 59.80 Bn | 1.37 Bn | 1,135.00 |
| 4 | Moderna | 58.86 Bn | 53.72 Bn | 52.00 Mn | 7,666.00 |
| 5 | BeOne Medicines | 42.03 Bn | 36.93 Bn | 1.53 Bn | 1,238.00 |
| 6 | Alnylam Pharmaceuticals | 31.54 Bn | 28.23 Bn | 992.69 Mn | 2,002.00 |
| 7 | BioNTech SE | 27.88 Bn | 9.49 Bn | 668.28 Mn | -3,558.00 |
| 8 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | 29,091.00 |
| 9 | Royalty Pharma | 27.35 Bn | 26.51 Bn | - | -1,651.00 |
| 10 | PharmaCyte Biotech | 4.38 Mn | 4.38 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2012 | -351,337.00 |
| Jul 31, 2012 | -482,909.00 |
| Apr 30, 2012 | -679,527.00 |
| Jan 31, 2012 | -180,774.00 |
| Oct 31, 2011 | -191,367.00 |
| Jul 31, 2011 | -300,802.00 |